Welcome : Guest

Advanced Accelerator Applications S.A. (France) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Advanced Accelerator Applications S.A., which is principally involved in Radiopharmaceuticals Business. Illustrated with 48 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65906
Price: $2400
Company Type: Public
Pages: 52
Date: March 2017
Market Data Tables: 48

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Advanced Accelerator Applications S.A.'s Sales by Product Category Worldwide (2014-2015) in Percentage for Positron Emission Tomography, Therapy, Other Products, and Single-photon Emission Computed Tomography......3
Table 2: Advanced Accelerator Applications S.A.'s Sales by Geographic Region Worldwide (2015) in Percentage for France, Italy, United Kingdom, Spain, Switzerland, Portugal, Israel, Germany, and Poland......4
Nuclear Medicine......7
Table 3: Nuclear Medicine Market by Type in India (2015) - Percentage Share Breakdown by Value Sales for Cyclotrons, Gamma Scanners, and PET Scanners......7
Table 4: Nuclear Medicine Market by Type in India (2015) - Percentage Share Breakdown by Volume Sales for Cyclotrons, Gamma Scanners, and PET Scanners......8
Cancer Drugs......9
Table 5: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......9
Table 6: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......10
Cancer Market......11
Table 7: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......11
Table 8: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......12
Table 9: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......13
Table 10: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......14
Table 11: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......15
Table 12: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......16
Table 13: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......17
Table 14: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......18
Cancer Patients......19
Table 15: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......19
Table 16: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Table 17: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......21
Table 18: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......22
Table 19: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......23
Table 20: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......24
Table 21: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......25
Table 22: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......26
Table 23: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......27
Table 24: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......28
Table 25: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......29
Table 26: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......30
Table 27: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......31
Table 28: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......32
Table 29: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......33
Table 30: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......34
Table 31: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......35
Table 32: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......36
Table 33: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......37
Table 34: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......38
Table 35: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......39
Injectable Somatostatin Analogues......40
Table 36: Injectable Somatostatin Analogues Market by Disorder Worldwide (2015) - Percentage Share Breakdown by Value for Acromegaly, Neuroendocrine, and Others......40
Tumor Necrosis Factor (TNF)......41
Table 37: Tumor Necrosis Factor (TNF) Inhibitors Market by Drug in China (2015) - Percentage Share Breakdown by Value for Enbrel, Remicade, Yisaipu, and Others......41
Neuroendocrine Tumors (NETs)......42
Table 38: Neuroendocrine Tumors (NETs) by Area in the US (2015) - Percentage Share Breakdown by Value for Gls & Unknown, Lung & Thymus, and Pancreas......42
Table 39: No. of Neuroendocrine Tumor Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, & Australia, Europe, and US......43
RadioPharmaceuticals......44
Table 40: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......44
Cancer Drugs......45
Table 41: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......45
Table 42: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......46
Table 43: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......47
Table 44: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......48
Table 45: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......49
Breast Cancer Drugs......50
Table 46: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......50
Neuroendocrine Tumors......51
Table 47: Market Shares of Leading Medication for the Treatment of Acromegaly & Neuroendocrine Tumors Worldwide (2015) - Percentage Share Breakdown by Value for Lanreotide, Octreotide Immediate-release (IR), and Octreotide Long-acting Release (LAR)......51
Positron Emission Tomography (PET) Equipment......52
Table 48: Market Shares of Leading Positron Emission Tomography (PET) Equipment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for GE Healthcare, Philips Healthcare, Siemens Healthcare GmbH, Toshiba Medical Systems Corporation and Others......52